Photothermal Particle-Loaded Panax Notoginseng Polysaccharide Cryogels As Personalized Tumor Vaccines
- PMID: 38859583
- DOI: 10.1021/acs.biomac.4c00442
Photothermal Particle-Loaded Panax Notoginseng Polysaccharide Cryogels As Personalized Tumor Vaccines
Abstract
Combination immunotherapy is being increasingly explored for cancer treatment, leading to various vector materials for the codelivery of immune agents and drugs. However, current tumor vaccines exhibit poor immunogenicity, severely compromising their therapeutic efficacy. Herein, an injectable hydrogel was developed based on dopamine (DA) and Panax notoginseng polysaccharide (PNPS) loaded with hair microparticles (HMPs) to enhance the immunogenicity of tumor vaccines. Photothermal effects of incorporated HMPs can trigger immunogenic cancer cell death and the release of abundant autologous tumor antigens, which are captured by catechol groups. Concomitant breakdown of PNPS recruits and activates dendritic cells (DCs). The macroporous structure of cryogels allows immune cell infiltration and interaction with antigens adsorbed on PNPS and DA cryogels (PD cryogels), thereby provoking potent cytotoxic T-cell responses. Hence, PD cryogels enabling cell infiltration and accelerated DC maturation may serve as a therapeutic vaccination platform against cancer.
Similar articles
-
Injectable and Degradable Zwitterionic Cryogels as Cancer Vaccine Platforms to Prevent Cancer Recurrence after Surgery.ACS Appl Bio Mater. 2024 Dec 16;7(12):8696-8708. doi: 10.1021/acsabm.4c01557. Epub 2024 Dec 4. ACS Appl Bio Mater. 2024. PMID: 39630107
-
Injectable cryogel-based whole-cell cancer vaccines.Nat Commun. 2015 Aug 12;6:7556. doi: 10.1038/ncomms8556. Nat Commun. 2015. PMID: 26265369 Free PMC article.
-
Structural characterization of a novel polysaccharide from Panax notoginseng residue and its immunomodulatory activity on bone marrow dendritic cells.Int J Biol Macromol. 2020 Oct 15;161:797-809. doi: 10.1016/j.ijbiomac.2020.06.117. Epub 2020 Jun 15. Int J Biol Macromol. 2020. PMID: 32553971
-
Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cells.Curr Opin Chem Biol. 2019 Dec;53:167-172. doi: 10.1016/j.cbpa.2019.10.001. Epub 2019 Oct 31. Curr Opin Chem Biol. 2019. PMID: 31678713 Review.
-
Dendritic cells as vectors for immunotherapy of cancer.Semin Cancer Biol. 2003 Dec;13(6):439-47. doi: 10.1016/j.semcancer.2003.09.008. Semin Cancer Biol. 2003. PMID: 15001163 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials